Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carol Forbes, Louis Lavoie, Sacha Satram, Ling Shen, Vaidehi Thanawala, Andre Arizpe & Norah Terrault. (2023) Global importance of new treatment strategies to efforts to control hepatitis B virus. Expert Review of Anti-infective Therapy 21:8, pages 847-862.
Read now
Read now
Tingting Shi, Hideki Kobara, Kyoko Oura & Tsutomu Masaki. (2021) Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. Journal of Hepatocellular Carcinoma 8, pages 45-55.
Read now
Read now
Articles from other publishers (36)
Qian Yang, Mohammed Abed Jawad, Abdullah Ali Alzahrani, Zahraa F Hassan, Ahmed Elawady, Ahmed Hjazi & Mehran Naghibi. (2024) Synergistic effects of Metformin and Forskolin on oxidative stress induced by diabetes and hepatocellular cancer: An animal study. Toxicon 243, pages 107720.
Crossref
Crossref
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri & Filomena Morisco. (2024) The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 16:8, pages 1505.
Crossref
Crossref
Habiba Kamal, Michael Ingre, Per Stål, Gabriel Westman, Daniel Bruce, Heiner Wedemeyer, Ann-Sofi Duberg & Soo Aleman. (2023) Age-specific and sex-specific risks for HCC in African-born persons with chronic hepatitis B without cirrhosis. Hepatology Communications 7:12.
Crossref
Crossref
Mona Mohamed Ibrahim Abdalla. (2023) Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. World Journal of Gastroenterology 29:27, pages 4271-4288.
Crossref
Crossref
Xueru He, Ying Li, Yajing Li, Caihui Guo, Yuhao Fu, Xuejiao Xun, Zhi Wang & Zhanjun Dong. (2023) In vivo assessment of the pharmacokinetic interactions between donafenib and dapagliflozin, donafenib and canagliflozin in rats. Biomedicine & Pharmacotherapy 162, pages 114663.
Crossref
Crossref
Tommaso Stroffolini & Giacomo Stroffolini. (2023) A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma. Cancers 15:8, pages 2388.
Crossref
Crossref
Wei-Syun Hu & Cheng-Li Lin. (2023) Sodium-Glucose Cotransporter-2 Inhibitor versus Beta-Blocker Use for Hepatocellular Carcinoma Risk among People with Hepatitis B or C Virus Infection and Diabetes Mellitus. Cancers 15:7, pages 2104.
Crossref
Crossref
Tzu-I Chen, Fu-Jen Lee, Wan-Lun Hsu, Yong-Chen Chen & Mingchih Chen. (2023) Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection. Cancers 15:4, pages 1148.
Crossref
Crossref
Takuma Nakatsuka & Ryosuke Tateishi. (2023) Development and prognosis of hepatocellular carcinoma in patients with diabetes. Clinical and Molecular Hepatology 29:1, pages 51-64.
Crossref
Crossref
Fatemeh Farshadpour, Reza Taherkhani & Fatemeh Saberi. (2022) Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case–control study. BMC Infectious Diseases 22:1.
Crossref
Crossref
Alexander M. Sy, Raphaella D. Ferreira & Binu V. John. (2022) Hepatocellular Carcinoma in Primary Biliary Cholangitis. Clinics in Liver Disease 26:4, pages 691-704.
Crossref
Crossref
Xueru He, Ying Li, Yinling Ma, Yuhao Fu, Xuejiao Xun, Yanjun Cui & Zhanjun Dong. (2022) Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats. Molecules 27:19, pages 6190.
Crossref
Crossref
Guanlun Zhou, Chao Chen, Guorong Han, Hongxiu Jiang & Minkai Cao. (2022)
Relationship between different hepatitis B virus infection status and gestational diabetes mellitus prevalence among pregnant women with chronic
HBV
infection: A retrospective study
. Journal of Viral Hepatitis 29:8, pages 596-603.
Crossref
Crossref
Dandan Mao, Eric S.H. Lau, Hongjiang Wu, Aimin Yang, Baoqi Fan, Mai Shi, Claudia H.T. Tam, Elaine Chow, Alice P.S. Kong, Ronald C.W. Ma, Andrea Luk & Juliana C.N. Chan. (2022) Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes. Hepatology Communications 6:6, pages 1350-1360.
Crossref
Crossref
Xiu Sun, Xin Chi, Yingying Zhao, Shunai Liu & Huichun Xing. (2022) Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus. Journal of Diabetes Research 2022, pages 1-14.
Crossref
Crossref
Chao Yang, Min Wan, Yifei Lu, Xian Yang, Ligang Yang, Shaokang Wang & Guiju Sun. (2022) Associations between diabetes mellitus and the risk of hepatocellular carcinoma in Asian individuals with hepatitis B and C infection: systematic review and a meta-analysis of cohort studies. European Journal of Cancer Prevention 31:2, pages 107-116.
Crossref
Crossref
Kaibo Lyu, Wei Yue, Junhua Ran, Yunjuan Liu & Xueliang Zhu. (2021)
In vivo
therapeutic exploring for
Mori folium
extract against type 2 diabetes mellitus in rats
. Bioscience Reports 41:12.
Crossref
Crossref
Shihui Lai, Zhipeng Quan, Yuesong Hao, Jun Liu, Zhiqian Wang, Luo Dai, Hongliang Dai, Songqing He & Bo Tang. (2021) Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Saleh A. Alqahtani & Massimo Colombo. (2021) Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma. Cells 10:11, pages 3091.
Crossref
Crossref
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich & E. Wolpert-Barraza. (2021) Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Revista de Gastroenterología de México (English Edition) 86:4, pages 403-432.
Crossref
Crossref
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich & E. Wolpert-Barraza. (2021) Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B. Revista de Gastroenterología de México 86:4, pages 403-432.
Crossref
Crossref
Dafeng Liu, Lingyun Zhou, Xinyi Zhang, Yilan Zeng, Lang Bai, Dongbo Wu & Hong Tang. (2021) Significantly Decreased Islet β Cell Function is Closely Associated with Hyperglycemia in Chronic Hepatitis B Patients. International Journal of Endocrinology 2021, pages 1-11.
Crossref
Crossref
James Lok & Kosh Agarwal. (2021) Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 13:7, pages 1333.
Crossref
Crossref
G. A. Stashuk, Ya. G. Moisyuk, D. Ya. Smirnova & O. V. Sumtsova. (2021) The Role of Perfusion Computed Tomography of the Liver in the Assessment of Hemodynamics in Patients with Compensated Cirrhosis of the Liver and the Presence of Type 2 Diabetes Mellitus. Pilot Study. Radiology - Practice:2, pages 62-71.
Crossref
Crossref
Wamidh H. Talib, Asma Ismail Mahmod, Sara Feras. Abuarab, Eliza Hasen, Amer A. Munaim, Shatha Khaled Haif, Amani Marwan Ayyash, Samar Khater, Intisar Hadi AL-Yasari & Lina T. Al Kury. (2021) Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products. Molecules 26:8, pages 2179.
Crossref
Crossref
Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn & Seung Up Kim. (2021) Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B. Hepatology Research 51:4, pages 406-416.
Crossref
Crossref
Cori Campbell, Tingyan Wang, Anna L. McNaughton, Eleanor Barnes & Philippa C. Matthews. (2020) Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis. Journal of Viral Hepatitis 28:3, pages 493-507.
Crossref
Crossref
Bo‐Yuan Huang, Min‐Ru Tsai, Jia‐Kai Hsu, Ching‐Yu Lin, Chih‐Lin Lin, Jui‐Ting Hu, Yi‐Wen Huang, Chun‐Jen Liu, Wan‐Jung Wu, Chih‐Feng Wu, Feng‐Yu Sung, Pei‐Jer Chen, Hao‐Jan Liang, Shi‐Ming Lin & Ming‐Whei Yu. (2020) Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma. Molecular Carcinogenesis 59:11, pages 1269-1279.
Crossref
Crossref
Joseph K. LimMindie H. NguyenW. Ray KimRobert GishPonni PerumalswamiIra M. Jacobson. (2020) Prevalence of Chronic Hepatitis B Virus Infection in the United States. American Journal of Gastroenterology 115:9, pages 1429-1438.
Crossref
Crossref
Iliana Doycheva, Talan Zhang, Waseem Amjad & Paul J. Thuluvath. (2020) Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. Journal of Clinical and Experimental Hepatology 10:4, pages 296-303.
Crossref
Crossref
Maysa Ahmed Mobasher, Hala Galal El-Tantawi & Karim Samy El-Said. (2020) Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in Rats. Reports of Biochemistry and Molecular Biology 9:1, pages 115-128.
Crossref
Crossref
Sherien M. El-Daly, Shaimaa A. Gouhar, Amira M. Gamal-Eldeen, Fatma F. Abdel Hamid, Magdi N. Ashour & Nahla S. Hassan. (2020) Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells. Anti-Cancer Agents in Medicinal Chemistry 19:18, pages 2197-2210.
Crossref
Crossref
Yifei Tan, Xiaoyun Zhang, Wei Zhang, Li Tang, Hanwei Yang, Ke Yan, Li Jiang, Jian Yang, Chuan Li, Jiayin Yang, Tianfu Wen, Huairong Tang & Lunan Yan. (2019) The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China. Cancer Epidemiology, Biomarkers & Prevention 28:12, pages 2038-2046.
Crossref
Crossref
Yun-Feng Zhu, Yi-Fei Tan, Xi Xu, Jin-Li Zheng, Bo-Han Zhang, Huai-Rong TangJia-Yin Yang. (2019) Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China. Medicine 98:50, pages e18319.
Crossref
Crossref
Zhenluo Jiang, Lili Shen, Shuwei Wang, Shengdong Wu, Yaoren Hu, Junming Guo & Liyun Fu. (2019) Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma. Cancer Medicine 8:17, pages 7278-7287.
Crossref
Crossref
Xueru He, Ying Li, Yinling Ma, Yuhao Fu, Xuejiao Xun, Yanjun Cui & Zhanjun Dong. (2022) Simultaneous Determination of Sorafenib and Dapagliflozin in Rat Plasma by UPLC MS-MS Method with Application in Pharmacokinetic Interactions Study. SSRN Electronic Journal.
Crossref
Crossref